المؤلفون: Milton Packer, Waheed Jamal, Stefan D. Anker, Stuart J. Pocock, João Pedro Ferreira, Javed Butler, Anne Pernille Ofstad, Gerasimos Filippatos, Martina Brueckmann, Egon Pfarr, Faiez Zannad

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), London School of Hygiene and Tropical Medicine (LSHTM), Berlin Institute of Health (BIH), Department of Medicine, University of Washington [Seattle], Imperial College London

المصدر: Lancet
Lancet, Elsevier, 2020, 396, pp.819-829. ⟨10.1016/S0140-6736(20)31824-9⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Type 2 diabetes, 030204 cardiovascular system & hematology, Body Mass Index, Angiotensin Receptor Antagonists, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Cause of Death, Internal medicine, Diabetes mellitus, Empagliflozin, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Benzhydryl Compounds, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Aged, Heart Failure, Clinical Trials as Topic, Ejection fraction, business.industry, Hazard ratio, Stroke Volume, General Medicine, Middle Aged, medicine.disease, 3. Good health, Death, Hospitalization, Patient Outcome Assessment, Diabetes Mellitus, Type 2, chemistry, Case-Control Studies, Heart failure, Cardiology, Drug Therapy, Combination, Female, Neprilysin, business, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b80a4812ab235e41f47b4573d502cdTest
https://doi.org/10.1016/s0140-6736Test(20)31824-9

المؤلفون: Diana Ferrao, João Pedro Ferreira, Francisco Vasques-Nóvoa, Patrick Rossignol, Abhinav Sharma, Faiez Zannad, Adelino F. Leite-Moreira

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Universidade do Porto, McGill University Health Center [Montreal] (MUHC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), BOZEC, Erwan, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Universidade do Porto = University of Porto

المصدر: BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, BMJ Journals, 2021, 9 (1), pp.e002408. ⟨10.1136/bmjdrc-2021-002408⟩
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)

مصطلحات موضوعية: Research design, Cardiovascular event, Cardiovascular and Metabolic Risk, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Renal function, Type 2 diabetes, 030204 cardiovascular system & hematology, Kidney, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Risk Factors, Internal medicine, Diabetes mellitus, medicine, Humans, In patient, 030212 general & internal medicine, Heart Failure, Clinical events, business.industry, diabetes complications, RC648-665, kidney diseases, medicine.disease, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Diabetes Mellitus, Type 2, Heart failure, cardiovascular system, Female, business, Glomerular Filtration Rate

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf168e6ba5056bff12c012dc9e618cfTest
https://hal.univ-lorraine.fr/hal-03310551Test

المؤلفون: Zohra Lamiral, Faiez Zannad, Stuart J. Pocock, Bertram Pitt, Patrick Rossignol, Karl Swedberg, John J.V. McMurray, João Pedro Ferreira, Dirk J. van Veldhuisen, John Vincent

المساهمون: Cardiovascular Centre (CVC)

المصدر: Circulation-Heart failure, 14(6):008075. LIPPINCOTT WILLIAMS & WILKINS

مصطلحات موضوعية: Male, medicine.medical_specialty, insulin, medicine.medical_treatment, Insulins, heart failure, body mass index, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Mineralocorticoid receptor, Risk Factors, Diabetes mellitus, Internal medicine, Diabetes Mellitus, medicine, Humans, 030212 general & internal medicine, mineralocorticoid receptor antagonists, eplerenone, Aged, RISK, Ejection fraction, business.industry, Insulin, MORTALITY, Middle Aged, medicine.disease, SPIRONOLACTONE, Eplerenone, Treatment Outcome, Heart failure, Cardiology, ALDOSTERONE, SURVIVAL, HEART-FAILURE, Female, Cardiology and Cardiovascular Medicine, business, Body mass index, Heart Failure, Systolic, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c98e1f1c5b88d5f6fd3befb45fdee81Test
https://hdl.handle.net/11370/dbf841cb-0721-4827-be9a-249998ad64aaTest

المؤلفون: Faiez Zannad, João Pedro Ferreira, António S. Barros, Susan Stienen, Thomas Thum, Christian Bär, Bertram Pitt, Nicolas Girerd, Patrick Rossignol

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], University of Amsterdam [Amsterdam] (UvA), Universidade do Porto, Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School [Hannover] (MHH), University of Michigan Medical School [Ann Arbor], University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, SS, JF, FZ and PR are supported by a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d'Avenir' program FIGHT-HF (reference: ANR-15-RHU-0004) and by the French PIA project 'Lorraine Université d'Excellence', reference ANR-15-IDEX-04-LUE, and by the Contrat de plan Etat-lorraine and FEDER lorraine. SS received funding from the European Society of Cardiology in form of an ESC Research Grant (R-2018-18686). TT was supported by the German Research Foundation (DFG Th903/18-1) and the ERANet Grant EXPERT (BMBF, Germany, research grant ERA-CVD JTC2016 EXPERT, 01KL1711). AB was supported by DOCnet (NORTE-01-0145-FEDER-000003), by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE (ISITE),Lorraine Université d'Excellence(2016), Publica, DE CARVALHO, Philippe, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Universidade do Porto = University of Porto, ANR-15-IDEX-0004,LUE,Isite LUE(2015), Cardiology, ACS - Heart failure & arrhythmias

المصدر: International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2021, S0167-5273 (21), pp.00399-5. ⟨10.1016/j.ijcard.2021.02.088⟩
International journal of cardiology, 332, 35-37. Elsevier Ireland Ltd

مصطلحات موضوعية: medicine.medical_specialty, Cardiac fibrosis, Myocardial Infarction, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Mineralocorticoid receptor, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Diabetes mellitus, medicine, Humans, 030212 general & internal medicine, Myocardial infarction, Mineralocorticoid Receptor Antagonists, Heart Failure, business.industry, medicine.disease, Eplerenone, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MicroRNAs, Heart failure, Cardiology, Biomarker (medicine), Cardiology and Cardiovascular Medicine, business, Type I collagen, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019b0969b765b92364cc19a71e333b16Test
https://hal.univ-lorraine.fr/hal-03166560/documentTest

المؤلفون: Faiez Zannad, Abhinav Sharma, Robert J. Mentz, Mona Fiuzat, Javed Butler, Christopher M. O'Connor, João Pedro Ferreira, Lauren B. Cooper, David Fitchett, Alan C. Moses

المصدر: JACC: Heart Failure. 6:813-822

مصطلحات موضوعية: Heart Failure, medicine.medical_specialty, business.industry, Atherosclerotic cardiovascular disease, 030204 cardiovascular system & hematology, Controlled studies, medicine.disease, Diabetes Complications, Clinical trial, 03 medical and health sciences, Glycemic management, 0302 clinical medicine, Diabetes Mellitus, Type 2, Heart failure, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, In patient, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Intensive care medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c016012bad116eafc8764949d3a954bcTest
https://doi.org/10.1016/j.jchf.2018.05.020Test

المؤلفون: Lutgarde Thijs, Beatrice Mariottoni, Johannes Petutschnigg, Andrew L. Clark, Mamas A. Mamas, Patrick Rossignol, Frank Edelmann, Pierpaolo Pellicori, Timothy Collier, Franco Cosmi, Fozia Z Ahmed, Arantxa González, João Pedro Ferreira, Blerim Mujaj, Mark R. Hazebroek, Joe Cuthbert, Philippe Rouet, Stephane Heymans, Hans-Peter Brunner-La Rocca, Nicolas Girerd, Job A J Verdonschot, Jan A. Staessen, John G.F. Cleland, Faiez Zannad

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), University of Hull [United Kingdom], Castle Hill Hospital, University of Manchester [Manchester], Manchester Academic Health Science Centre (MAHSC), Keele University [Keele], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), Clínica Universidad de Navarra [Pamplona], CIBERCV, Carlos III Institute of Health, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Charité Campus Virchow-Klinikum (CVK), Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University of Glasgow, Cortona Hospital, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). JPF, PR, NG, FZ are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), by the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP and FEDER Lorraine., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), European Project, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Freiburg University Medical Center, Hôpital de Rangueil, CHU Toulouse [Toulouse], Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Artsass Cardiologie (9), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, Entreprises lorraines, parties prenantes et Développement Durable (FEDER) (Région Lorraine) - INCOMING

المصدر: European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. Oxford University Press

مصطلحات موضوعية: cardiovascular risk, Male, medicine.medical_specialty, ALDOSTERONISM, hypertension, IMPACT, Developing heart, Blood Pressure, 030204 cardiovascular system & hematology, Spironolactone, Sitting, Coronary artery disease, RESISTANT HYPERTENSION, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Diabetes mellitus, Renin–angiotensin system, medicine, MANAGEMENT, FIBROSIS, Humans, Pharmacology (medical), 030212 general & internal medicine, Prospective Studies, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, business.industry, R735, medicine.disease, Omics, RC666, R1, PREVENTION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Blood pressure, spironolactone, chemistry, renin, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, TASK-FORCE

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51291ffb39695fa7fd47e8e135cb3fa6Test
https://pubmed.ncbi.nlm.nih.gov/33822033Test

المؤلفون: Giuseppe Mancia, Thomas Weber, Reinhold Kreutz, Otto A. Smiseth, Kristian Wachtell, Faiez Zannad, Sverre E. Kjeldsen, Enrico Agabiti Rosei, Athanasios J. Manolis, Konstantinos Tsioufis, João Pedro Ferreira, Miguel Camafort, Thomas G. von Lueder, Georg Ehret, Alexandros Kasiakogias, Andrzej Januszewicz, Thomas Kahan, Jana Brguljan, Luca Faconti

مصطلحات موضوعية: medicine.medical_specialty, Finerenone, Physiology, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, law.invention, Angiotensin Receptor Antagonists, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Diabetes mellitus, Internal Medicine, medicine, Humans, 030212 general & internal medicine, Risk factor, Intensive care medicine, Heart Failure, business.industry, Stroke Volume, medicine.disease, Blood pressure, chemistry, Heart failure, Hypertension, Spironolactone, Cardiology and Cardiovascular Medicine, business, Heart failure with preserved ejection fraction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a1c2bd18e7752775c603525b4c2795Test
http://hdl.handle.net/10852/92304Test

المؤلفون: Gerasimos Filippatos, Stuart J. Pocock, Javed Butler, Peter E. Carson, Waheed Jamal, Sven Schnaidt, Stefan D. Anker, Martina Brueckmann, John R. Teerlink, Wolfram Doehner, Milton Packer, Cordula Zeller, Alan B. Miller, Faiez Zannad, S. Pehrson, Markus Haass, Inder S. Anand, Michel Komajda, João Pedro Ferreira

المصدر: Circulation. 143(4)

مصطلحات موضوعية: Heart Failure, medicine.medical_specialty, Ejection fraction, business.industry, 030204 cardiovascular system & hematology, medicine.disease, Cardiovascular death, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Physiology (medical), Internal medicine, Diabetes mellitus, Heart failure, medicine, Cardiology, Empagliflozin, Humans, In patient, 030212 general & internal medicine, Benzhydryl Compounds, Cardiology and Cardiovascular Medicine, business, Sodium-Glucose Transporter 2 Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601e00dfdd2177a900fc500feae54924Test
https://pubmed.ncbi.nlm.nih.gov/34526679Test

المؤلفون: Faiez Zannad, António S. Barros, João Pedro Ferreira, Jacques-Eric Gottenberg, Rita Costa, Patrick Rossignol, José Carlos Oliveira, Henrique Carvalho, Francisca Saraiva, Tomás Fonseca, Patrícia Rodrigues, Maria Betânia Ferreira, António Marinhoc

المصدر: European journal of internal medicine. 85

مصطلحات موضوعية: Proteomics, medicine.medical_specialty, Inflammation, 030204 cardiovascular system & hematology, Arthritis, Rheumatoid, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Prevalence, Humans, 030212 general & internal medicine, Heart Failure, business.industry, Atrial fibrillation, medicine.disease, Adrenomedullin, Rheumatoid arthritis, Heart failure, Cardiology, medicine.symptom, business, Dyslipidemia, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c901fc581d3cc9a6fe14e84956ab06ceTest
https://pubmed.ncbi.nlm.nih.gov/33162300Test

المؤلفون: Marco Metra, Carlo Lombardi, Chim C. Lang, Valentina Carubelli, Nilesh J. Samani, Kenneth Dickstein, Faiez Zannad, Leong L. Ng, John G.F. Cleland, Piotr Ponikowski, João Pedro Ferreira, Gerasimos Filippatos, Stefan D. Anker, Dirk J. van Veldhuisen, Adriaan A. Voors

المساهمون: Cardiovascular Centre (CVC)

المصدر: Clinical Research in Cardiology, 109(8), 967-977. SPRINGER HEIDELBERG

مصطلحات موضوعية: Male, medicine.medical_specialty, Geographical differences, SOCIETY, Signs and symptoms, Angiotensin-Converting Enzyme Inhibitors, Heart failure, 030204 cardiovascular system & hematology, Treatment up-titration, 03 medical and health sciences, Angiotensin Receptor Antagonists, 0302 clinical medicine, Internal medicine, Diabetes mellitus, Clinical endpoint, Medicine, Humans, SOCIOECONOMIC-STATUS, 030212 general & internal medicine, Prospective Studies, RATES, Aged, BIOSTAT-CHF, Geographical variations, Income, Outcomes, OUTCOMES, INCOME, business.industry, Incidence, MORTALITY, Kidney dysfunction, General Medicine, medicine.disease, Prognosis, TRENDS, Clinical trial, Target dose, Europe, HOSPITALIZATION, Baseline characteristics, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, OUTPATIENTS, Demography, MIDDLE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c158e2db3758e172d24de759576f582Test
https://research.rug.nl/en/publications/8dec45a2-5e61-4ad6-809a-9ccd1ce816ebTest